📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
With big pharma circling psychedelics, the next breakthrough may not come from tripping at all
When AbbVie moved to acquire Gilgamesh Pharmaceuticals in a deal valued at more than $1 billion, it sent shockwaves through the biotech community. For years, psychedelic-inspired drug development has been viewed as a ...
Gonzo Metaphysics
Psychedelics, Philosophy, and the Metaphysical Turn
Was the Life-Extending Psilocybin Study All Hype?
One academic says yes. PLUS an interview with an Onanya, AI generated DMT visuals, and psilocybin's impact on shame. [...] Read More... The post Was the Life-Extending Psilocybin Study All Hype? appeared first on Doub...
Psychedelic resources for you to explore 🤩
Plus, details of three autumn conferences in Europe 🤝
Bridging Psychedelics, Psychiatry, and Spirituality for Global Healing
As psychedelic medicine continues its rapid reentry into mainstream science, few voices have managed to bridge the worlds of psychiatry, spirituality, and policy as seamlessly as Dr. Anna Yusim. With training at Stanf...
Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice
This pre-clinical mouse study tested chronic administration of serotonin, d-fenfluramine, or subhallucinogenic doses of LSD on cardiovascular health. Serotonin and d-fenfluramine caused ventricular thickening and valv...
What Happens When You Mix MDMA and Viagra?
The short answer: yes...but with a few caveats. [...] Read More... The post What Happens When You Mix MDMA and Viagra? appeared first on DoubleBlind Mag.
Everything to Know About the New Potent Psilocybin Mushroom
Discovered in 2023, Psilocybe ingeli grows fast, packs serious potency, and could be a game-changer for cultivators...and consumers. [...] Read More... The post Everything to Know About the New Potent Psilocybin Mushr...
MAPS Board of Directors Names Betty Aldworth and Ismail Lourido Ali as Co-Executive Directors
September 9, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization at the vanguard of the psychedelic movement since 1986, today announced that its Board of Direct...
Why Psychedelics Are Emerging as a Powerful Tool for Recovery
PLUS: Should psychedelic researchers disclose personal use of the drugs they study? [...] Read More... The post Why Psychedelics Are Emerging as a Powerful Tool for Recovery appeared first on DoubleBlind Mag.
Wixárika Pilgrimage Route Earns UNESCO World Heritage Status
This is a massive win for the Wixiárika and other Indigenous communities across the Americas. [...] Read More... The post Wixárika Pilgrimage Route Earns UNESCO World Heritage Status appeared first on DoubleBlind Mag.
MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy
San Jose, CA; September 4, 2025 — In August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic...
Skin in the Game: Why Psychedelic Therapists Should Share Patient Risks
Plenty of ink has been spilled over whether psychedelic therapists should have their own psychedelic experiences. I’m not going to rehash existing arguments, but sketch an idea that I don’t think has gotten enough ...
Mind Gardens
On the Propensity for Psychedelic-Induced Nature-Connectedness and the Demand for New Sacred Spaces
Are Psilocybin Mushrooms As Old As the Dinosaurs?
Psilocybin fungi clearly have potent (and ancient) survival strategies. [...] Read More... The post Are Psilocybin Mushrooms As Old As the Dinosaurs? appeared first on DoubleBlind Mag.